NCT06265623View on ClinicalTrials.gov

Intermittent Hypoxemia, Lung Function Decline, Morbidity, and Mortality in COPD (PROSA Study).

Not yet recruitingOBSERVATIONAL

Enrollment

148

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2029

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

OTHER

No active intervention, but observational follow-up

Patients remain in usual care by their pulmonary medicine specialists and are being observed during annual follow-up investigations during up to 3 years

Trial Locations (1)

20246

University Medical Center Hamburg-Eppendorf, Institute of Clinical Pharmacology and Toxicology, Hamburg

All Listed Sponsors

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT06265623 - Intermittent Hypoxemia, Lung Function Decline, Morbidity, and Mortality in COPD (PROSA Study). | Biotech Hunter | Biotech Hunter